ALEKSEY KRETOV: Open Payments
NPI 1811184211 · OAKHURST, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,238 in 112 payments from 23 companies in 2025. Trend: 2023 $3,597 · 2024 $2,796 · 2025 $2,238
Food & beverage: $2,229Education: $10
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 19 | $488 |
| ABBVIE INC. | 21 | $410 |
| Amgen Inc. | 21 | $408 |
| Phathom Pharmaceuticals, Inc. | 9 | $132 |
| Exact Sciences Corporation | 2 | $121 |
| Novo Nordisk Inc | 7 | $109 |
| Lilly USA, LLC | 5 | $94 |
| GlaxoSmithKline, LLC. | 5 | $80 |
| Novartis Pharmaceuticals Corporation | 3 | $50 |
| Aimmune Therapeutics, Inc. | 3 | $47 |
Products named: BREZTRI, FARXIGA, REPATHA, OTEZLA, VOQUEZNA, Cologuard Collection Kit, CREON, KRYSTEXXA.
Industry payments across NJ — which companies pay providers there.
